|
|
Article: The Susan G. Komen Breast Cancer Foundation Encouraged by Results of New Study on Non-Hormonal Remedy for Hot Flashes.
- Article from:
- PR Newswire
- Article date:
- May 22, 2000
CopyrightCOPYRIGHT 2000 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Data Suggests Venlafaxine, a Newer Antidepressant, Alleviates
Hot Flashes in Breast Cancer Survivors by 60 Percent
NEW ORLEANS, May 22 /PRNewswire/ --
A study conducted by the North Central Cancer Treatment Group (NCCT), a cooperative cancer research group based at the Mayo Clinic, Rochester, Minn., found that venlafaxine, a non-hormonal antidepressant, alleviates hot flashes by an average of 60 percent in breast cancer survivors. The data from the study was presented today at the 36th Annual Meeting of the American Society of Clinical Oncology (ASCO).
Hot flashes are a significant problem for many menopausal women. Women with breast ...